Also trades as: EMBCV (NASDAQ) · $vol 116M

$3.32

+0.00 (+0.00%)

Weekly Expected Move ±29.4%

$1 $2 $3 $4 $5

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 29 · $197.0M mcap · 58M float · 2.95% daily turnover · Short 51% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$1.1B -3.8% ▼

5Y CAGR: -0.1%

Gross Profit

$680M -6.8% ▼

5Y CAGR: -2.3%

Operating Income

$329M +89.0% ▲

5Y CAGR: -7.5%

Net Income

$95M +21.8% ▲

5Y CAGR: -25.9%

EPS (Diluted)

$1.62 +20.9% ▲

5Y CAGR: -26.4%

EBITDA

$295M +48.1% ▲

5Y CAGR: -10.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.2B	$1.1B	$1.1B	$1.1B	$1.1B
YoY Growth	+7.3%	-3.0%	-0.8%	+0.2%	-3.8%
Cost of Revenue	$365M	$355M	$371M	$388M	$401M
Gross Profit	$800M	$775M	$750M	$735M	$680M
Gross Margin	68.7%	68.6%	66.9%	65.5%	62.9%
R&D Expenses	$63M	$67M	$85M	$79M	$22M
SG&A Expenses	$240M	$295M	$341M	$365M	$331M
Operating Expenses	$308M	$465M	$528M	$568M	$350M
Operating Income	$492M	$310M	$222M	$167M	$329M
Operating Margin	42.2%	27.4%	19.8%	14.9%	30.5%
Interest Expense	$0	$46M	$107M	$112M	$107M
Income Before Tax	$495M	$257M	$106M	$44M	$136M
Tax Expense	$80M	$33M	$35M	-$34M	$41M
Net Income	$415M	$224M	$70M	$78M	$95M
Net Margin	35.6%	19.8%	6.3%	7.0%	8.8%
EPS (Diluted)	$7.31	$3.89	$1.22	$1.34	$1.62
EBITDA	$530M	$400M	$245M	$193M	$295M
Shares Outstanding	57M	57M	58M	58M	59M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$272M	$286M	$262M	$259M	$296M	$264M	$261M	$222M
Cost of Revenue	$82M	$112M	$105M	$95M	$100M	$108M	$86M	$97M
Gross Profit	$190M	$174M	$157M	$164M	$195M	$156M	$176M	$125M
Gross Margin	69.8%	60.7%	60.0%	63.4%	66.0%	59.1%	67.2%	56.4%
R&D Expenses	$20M	$20M	$20M	$8M	$4M	$5M	$300K	$10M
SG&A Expenses	$86M	$97M	$81M	$80M	$84M	$87M	$78M	$76M
Operating Expenses	$134M	$148M	$128M	$101M	$89M	$92M	$78M	$82M
Operating Income	$56M	$26M	$29M	$63M	$106M	$64M	$97M	$43M
Operating Margin	20.5%	9.2%	11.0%	24.3%	35.9%	24.4%	37.2%	19.3%
Interest Expense	$28M	$29M	$28M	$27M	$27M	$26M	$24M	$23M
Income Before Tax	$27M	-$7M	-$700K	$36M	$72M	$29M	$59M	$10M
Tax Expense	$12M	-$22M	-$700K	$12M	$27M	$3M	$15M	$14M
Net Income	$15M	$15M	-$700K	$24M	$46M	$26M	$44M	-$4M
Net Margin	5.4%	5.1%	-0.3%	9.1%	15.4%	10.0%	16.9%	-1.8%
EPS (Diluted)	$0.25	$0.25	$-0.01	$0.40	$0.78	$0.45	$0.74	$-0.07
EBITDA	$66M	$34M	$39M	$74M	$111M	$71M	$96M	$56M
Shares Outstanding	58M	58M	59M	59M	58M	59M	59M	59M

EMBC NASDAQ